Long-acting injectable antipsychotic care coordination in the medical hospital

被引：0
|
作者：
Kistlera, Elizabeth A. [1 ,2 ]
Gopalana, Priya R. [1 ,2 ]
Gannona, Jessica M. [1 ,2 ]
Brarb, Jaspreet S. [2 ]
Then, Janine [3 ]
Shenaia, Neeta [1 ,2 ]
Chengappa, K. N. Roy [1 ,2 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA
[2] Univ Pittsburgh Med Ctr, Western Psychiat Hosp, Pittsburgh, PA USA
[3] Univ Pittsburgh Med Ctr, Presbyterian Hosp, Pittsburgh, PA USA
来源：
GENERAL HOSPITAL PSYCHIATRY | 2024年 / 90卷
关键词：
SCHIZOPHRENIA;
D O I：
10.1016/j.genhosppsych.2024.05.006
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：183 / 185
页数：3
相关论文
共 50 条
  • [31] Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
    Maini, Kunal
    Gould, Haley
    Hicks, Jessica
    Iqbal, Fatima
    Patterson, James, II
    Edinoff, Amber N.
    Cornett, Elyse M.
    Kaye, Adam M.
    Viswanath, Omar
    Urits, Ivan
    Kaye, Alan D.
    NEUROLOGY INTERNATIONAL, 2021, 13 (03) : 279 - 296
  • [32] A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
    Henry A Nasrallah
    Srihari Gopal
    Cristiana Gassmann-Mayer
    Jorge A Quiroz
    Pilar Lim
    Mariëlle Eerdekens
    Eric Yuen
    David Hough
    Neuropsychopharmacology, 2010, 35 : 2072 - 2082
  • [33] Retrospective audit of people treated with long-acting antipsychotic injectable medications: Usage patterns and outcomes
    Lee, Stuart J.
    de Castella, Anthony
    Stafrace, Simon
    Keppich-Arnold, Sandra
    Kulkarni, Jayashri
    SCHIZOPHRENIA RESEARCH, 2018, 197 : 572 - 573
  • [34] Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia
    Delbert G. Robinson
    Mark Suett
    Amanda Wilhelm
    Nayla Chaijale
    Kelli R. Franzenburg
    Sanjay Gandhi
    Blaine Cloud
    Marko Mychaskiw
    Advances in Therapy, 2023, 40 : 2249 - 2264
  • [35] Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders
    Sahin, Olcay Senay
    Mursalova, Zhala
    Gadimov, Shahriyar
    Ucok, Alp
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 251 - 256
  • [36] An unusual complication of a long-acting injectable antipsychotic: deep venous thrombosis caused by olanzapine pamoate
    Tunc, Serhat
    Basbug, Hamit Serdar
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2018, 28 (02) : 211 - 214
  • [37] Long-Acting Injectable Antipsychotic Medications Why Aren't They Used as Often as Oral Formulations?
    Limandri, Barbara J.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2019, 57 (03) : 7 - 10
  • [38] Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians
    Reinstein, Sarah A.
    Cosgrove, Jessica
    Malekshahi, Tara
    Deligiannidis, Kristina M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (06)
  • [39] Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia
    Robinson, Delbert G.
    Suett, Mark
    Wilhelm, Amanda
    Chaijale, Nayla
    Franzenburg, Kelli R.
    Gandhi, Sanjay
    Cloud, Blaine
    Mychaskiw, Marko
    ADVANCES IN THERAPY, 2023, 40 (05) : 2249 - 2264
  • [40] Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
    Christina Leotsakou
    Sofia Kessidou
    Aikaterini Kalogeropoulou
    Ioanna Fotara
    Perikles Robotis
    Christina Karkatzouli
    Demetrios Gousis
    Athanasios Demetriades
    Maria Giovanoglou
    Perikles Paterakis
    Annals of General Psychiatry, 7 (Suppl 1)
12345